top of page

CJC-1295 – No DAC – 10mg

$60.00Price
Quantity
Expect within 5 days

B's Research Labs | Research Overview

B's Research Labs CJC-1295 without DAC, also known as Modified GRF (1–29), is a synthetic 29-amino-acid analogue of growth hormone–releasing hormone (GHRH). Its molecular structure incorporates four amino-acid substitutions that distinguish it from the naturally occurring GHRH sequence and contribute to its biochemical stability and receptor-binding characteristics. Unlike CJC-1295 with DAC, this compound does not contain a Drug Affinity Complex (DAC) or an albumin-binding modification. This structural distinction makes it a compound of interest in comparative peptide chemistry, molecular biology, receptor-binding studies, and biochemical research. Supplied in a 10 mg lyophilized powder format, CJC-1295 without DAC is intended exclusively for controlled laboratory research and analytical applications. Laboratory investigations may focus on peptide stability, molecular structure, receptor-binding characteristics, biochemical interactions, and compound behavior under controlled experimental conditions. Research involving CJC-1295 without DAC may also examine GHRH receptor interactions and associated molecular signaling pathways. These investigations remain experimental and do not establish clinical safety, efficacy, or suitability for administration. The DAC-modified analogue is identified separately due to differences in molecular structure and albumin-binding characteristics.


RUO — RESEARCH USE ONLY

For in vitro laboratory research and analytical applications only.

NOT FOR HUMAN OR VETERINARY USE. NOT FOR CONSUMPTION, INJECTION, INGESTION, OR CLINICAL ADMINISTRATION.

Not intended for diagnostic, therapeutic, pharmaceutical, cosmetic, or personal use. No claims are made regarding safety, efficacy, or suitability for human or animal applications.


Compound Identification

CJC-1295 without DAC refers to Modified GRF (1–29), a synthetic 29-amino-acid GHRH analogue without a Drug Affinity Complex modification.

    bottom of page